13D/13G Filings - Seres Therapeutics Inc. (MCRB)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-09-08
1:28 pm
Sale
2020-08-31 13G Seres Therapeutics, Inc.
MCRB
Nikko Asset Management Americas, Inc. 281,250
6.300%
-132,412decrease
(-32.01%)
Filing
History
2020-08-19
5:17 pm
Purchase
2020-08-17 13D Seres Therapeutics, Inc.
MCRB
Nestle Health Science US Holdings Inc. 394,645
8.800%
394,645increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2